Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
While systemic research in humans remains extremely limited, preclinical work in mice suggests a pathway through which GHK-Cu may alter neurodegenerative processes
A peer-reviewed study published in JMIR Formative Research found that active subscribers on Second Natures semaglutide-supported programme lost an average of 19.1% of their body weight at 12 months, with 77.7% achieving at least 10% weight loss
Semaglutide and tirzepatide are also active pharmaceutical ingredients used in certain FDA-approved medications, but a compounded preparation is a separate, non-FDA-approved product and isn't the same regulatory product as those branded drugs
Such conditions place significant strain on existing manufacturing infrastructure, particularly in areas such as injection molding, assembly, and sterilization
